Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2018 Jun 20

PMID 29915589

Citations 6

Authors

Noortje de Haan

Maarten J D Van Tol

Gertjan J Driessen

Manfred Wuhrer

Arjan C Lankester

Affiliations

Soon will be listed here.

Abstract

Immunoglobulin G (IgG) fragment crystallizable (Fc) -glycosylation has a large influence on the affinity of the antibody for binding to Fcγ-receptors (FcγRs) and C1q protein, thereby influencing immune effector functions. IgG Fc glycosylation is known to be partly regulated by genetics and partly by stimuli in the microenvironment of the B cell. Following allogeneic hematopoietic stem cell transplantation (HSCT), and in the presence of (almost) complete donor chimerism, IgG is expected to be produced by, and glycosylated in, B cells of donor origin. We investigated to what extent IgG glycosylation in patients after transplantation is determined by factors of the donor (genetics) or the recipient (environment). Using an IgG subclass-specific liquid chromatography-mass spectrometry method, we analyzed the plasma/serum IgG Fc glycosylation profiles of 34 pediatric patients pre-HSCT and at 6 and 12 months post-HSCT and compared these to the profiles of their donors and age-matched healthy controls. Patients treated for hematological malignancies as well as for non-malignant hematological diseases showed after transplantation a lower Fc galactosylation than their donors. Especially for the patients treated for leukemia, the post-HSCT Fc glycosylation profiles were more similar to the pre-HSCT recipient profiles than to profiles of the donors. Pre-HSCT, the leukemia patient group showed as distinctive feature a decrease in sialylation and in hybrid-type glycans as compared to healthy controls, which both normalized after transplantation. Our data suggest that IgG Fc glycosylation in children after HSCT does not directly mimic the donor profile, but is rather determined by persisting environmental factors of the host.

Citing Articles

Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.

Purcell R, Theisen R, Arnold K, Chung A, Selva K Front Immunol. 2023; 14:1183727.

PMID: 37600816 PMC: 10433199. DOI: 10.3389/fimmu.2023.1183727.

Analysis of monoclonal immunoglobulins from bone marrow plasma cells using immunopurification and LC-MS.

Barnidge D, Dispenzieri A, Jevremovic D, Murray D J Mass Spectrom Adv Clin Lab. 2023; 28:133-141.

PMID: 37138663 PMC: 10149385. DOI: 10.1016/j.jmsacl.2023.04.001.

Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

DallOlio F, Malagolini N Exp Suppl. 2021; 112:303-340.

PMID: 34687015 DOI: 10.1007/978-3-030-76912-3_10.

Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant.

McQuiston A, Emtiazjoo A, Angel P, Machuca T, Christie J, Atkinson C Front Immunol. 2021; 12:711102.

PMID: 34456920 PMC: 8385565. DOI: 10.3389/fimmu.2021.711102.

Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.

Prenc E, Pulanic D, Pucic-Bakovic M, Ugrina I, Desnica L, Milosevic M Front Immunol. 2021; 12:633214.

PMID: 34335560 PMC: 8317462. DOI: 10.3389/fimmu.2021.633214.

References

Ercan A, Kohrt W, Cui J, Deane K, Pezer M, Yu E . Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2017; 2(4):e89703. PMC: 5313059. DOI: 10.1172/jci.insight.89703. View

Kaneko Y, Nimmerjahn F, Ravetch J . Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006; 313(5787):670-3. DOI: 10.1126/science.1129594. View

Qian Y, Wang Y, Zhang X, Zhou L, Zhang Z, Xu J . Quantitative analysis of serum IgG galactosylation assists differential diagnosis of ovarian cancer. J Proteome Res. 2013; 12(9):4046-55. DOI: 10.1021/pr4003992. View

Wang J, Balog C, Stavenhagen K, Koeleman C, Scherer H, Selman M . Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Proteomics. 2011; 10(5):M110.004655. PMC: 3098587. DOI: 10.1074/mcp.M110.004655. View

Dekkers G, Treffers L, Plomp R, Bentlage A, de Boer M, Koeleman C . Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities. Front Immunol. 2017; 8:877. PMC: 5539844. DOI: 10.3389/fimmu.2017.00877. View

Driessen G, Dalm V, van Hagen P, Grashoff H, Hartwig N, van Rossum A . Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum. Haematologica. 2013; 98(10):1617-23. PMC: 3789468. DOI: 10.3324/haematol.2013.085076. View

Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O . High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics. 2011; 10(10):M111.010090. PMC: 3205872. DOI: 10.1074/mcp.M111.010090. View

Wahl A, van den Akker E, Klaric L, Stambuk J, Benedetti E, Plomp R . Genome-Wide Association Study on Immunoglobulin G Glycosylation Patterns. Front Immunol. 2018; 9:277. PMC: 5834439. DOI: 10.3389/fimmu.2018.00277. View

Bakovic M, Selman M, Hoffmann M, Rudan I, Campbell H, Deelder A . High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J Proteome Res. 2013; 12(2):821-31. DOI: 10.1021/pr300887z. View

10.

Lu L, Chung A, Rosebrock T, Ghebremichael M, Yu W, Grace P . A Functional Role for Antibodies in Tuberculosis. Cell. 2016; 167(2):433-443.e14. PMC: 5526202. DOI: 10.1016/j.cell.2016.08.072. View

11.

Pezer M, Stambuk J, Perica M, Razdorov G, Banic I, Vuckovic F . Effects of allergic diseases and age on the composition of serum IgG glycome in children. Sci Rep. 2016; 6():33198. PMC: 5018987. DOI: 10.1038/srep33198. View

12.

de Jong S, Selman M, Adegnika A, Amoah A, van Riet E, Kruize Y . IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci Rep. 2016; 6:28207. PMC: 4910062. DOI: 10.1038/srep28207. View

13.

de Haan N, Reiding K, Driessen G, van der Burg M, Wuhrer M . Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood. J Proteome Res. 2016; 15(6):1853-61. DOI: 10.1021/acs.jproteome.6b00038. View

14.

Vuckovic F, Theodoratou E, Thaci K, Timofeeva M, Vojta A, Stambuk J . IgG Glycome in Colorectal Cancer. Clin Cancer Res. 2016; 22(12):3078-86. PMC: 5860729. DOI: 10.1158/1078-0432.CCR-15-1867. View

15.

Maier M, Reusch D, Bruggink C, Bulau P, Wuhrer M, Molhoj M . Applying mini-bore HPAEC-MS/MS for the characterization and quantification of Fc N-glycans from heterogeneously glycosylated IgGs. J Chromatogr B Analyt Technol Biomed Life Sci. 2016; 1033-1034:342-352. DOI: 10.1016/j.jchromb.2016.08.001. View

16.

Pucic M, Muzinic A, Novokmet M, Skledar M, Pivac N, Lauc G . Changes in plasma and IgG N-glycome during childhood and adolescence. Glycobiology. 2012; 22(7):975-82. DOI: 10.1093/glycob/cws062. View

17.

Jones M, Oswald D, Joshi S, Whiteheart S, Orlando R, Cobb B . B-cell-independent sialylation of IgG. Proc Natl Acad Sci U S A. 2016; 113(26):7207-12. PMC: 4932940. DOI: 10.1073/pnas.1523968113. View

18.

Bondt A, Rombouts Y, Selman M, Hensbergen P, Reiding K, Hazes J . Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics. 2014; 13(11):3029-39. PMC: 4223489. DOI: 10.1074/mcp.M114.039537. View

19.

Kemna M, Plomp R, van Paassen P, Koeleman C, Jansen B, Damoiseaux J . Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis. EBioMedicine. 2017; 17:108-118. PMC: 5360573. DOI: 10.1016/j.ebiom.2017.01.033. View

20.

Quast I, Keller C, Maurer M, Giddens J, Tackenberg B, Wang L . Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest. 2015; 125(11):4160-70. PMC: 4639970. DOI: 10.1172/JCI82695. View